{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:41:26Z","timestamp":1775094086503,"version":"3.50.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.clinthera.2011.09.029","type":"journal-article","created":{"date-parts":[[2011,10,31]],"date-time":"2011-10-31T13:51:06Z","timestamp":1320069066000},"page":"1590-1608","source":"Crossref","is-referenced-by-count":13,"title":["Focus on Phosphodiesterase Inhibitors for the Treatment of Erectile Dysfunction in Older Men"],"prefix":"10.1016","volume":"33","author":[{"given":"Mary","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.09.029_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-139-3-200308050-00005","article-title":"Sexual function in men older than 50 years of age: results from the Health Professionals Follow-Up Study","volume":"139","author":"Bacon","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2011.09.029_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.ju.0000164463.19239.19","article-title":"Chapter 1: the management of erectile dysfunction: an AUA update","volume":"174","author":"Montague","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-151-9-200911030-00151","article-title":"Hormonal testing and pharmacologic treatment of erectile dysfunction: a clinical practice guideline from the American College of Physicians","volume":"151","author":"Qaseem","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2011.09.029_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.ijir.3900949","article-title":"Epidemiology of erectile dysfunction","volume":"15","author":"Kubin","year":"2003","journal-title":"Intern J Impot Res"},{"key":"10.1016\/j.clinthera.2011.09.029_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0025-7125(16)30076-1","article-title":"Assessment and treatment of impotence","volume":"79","author":"O'Keefe","year":"1995","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.clinthera.2011.09.029_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4065\/84.2.139","article-title":"Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions","volume":"84","author":"Nehra","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2011.09.029_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-151-9-200911030-00150","article-title":"Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis","volume":"151","author":"Tsertsvadze","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2011.09.029_bib9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/archinte.162.12.1349","article-title":"Sildenafil for male erectile dysfunction","volume":"162","author":"Fink","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2011.09.029_bib10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1743-6109.2009.01547.x","article-title":"Vardenafil improves erectile function in men with erectile dysfunction and associated underlying conditions, irrespective of the use of concomitant medications","volume":"7","author":"Eardley","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2011.09.029_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ucl.2007.08.013","article-title":"Phosphodiesterase type 5 inhibitors: state of the therapeutics class","volume":"34","author":"Carson","year":"2007","journal-title":"Urol Clin North Am"},{"issue":"Suppl 2B","key":"10.1016\/j.clinthera.2011.09.029_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0090-4295(02)01687-4","article-title":"The efficacy of sildenafil citrate (Viagra) in clinical populations: an update","volume":"60","author":"Carson","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2011.09.029_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bmj.332.7541.589","article-title":"Treating erectile dysfunction when PDE5 inhibitors fail","volume":"332","author":"McMahon","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2011.09.029_bib14","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1464-410X.2005.05892.x","article-title":"An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men na\u00efve to phosphodiesterase 5 inhibitor therapy","volume":"96","author":"Eardley","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.clinthera.2011.09.029_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.eururo.2003.11.030","article-title":"A multicenter, randomized, double-blind crossover study to evaluate patient preference between tadalafil and sildenafil","volume":"45","author":"von Keitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib16","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/S0149-2918(03)80328-4","article-title":"A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction","volume":"25","author":"Govier","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.09.029_bib17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1743-6109.2006.00297.x","article-title":"Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors","volume":"3","author":"Tolra","year":"2006","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2011.09.029_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.mou.0000250286.60237.a6","article-title":"Management of sildenafil treatment failures","volume":"16","author":"Kendirci","year":"2006","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib19","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/01.ju.0000136448.71773.2b","article-title":"Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial","volume":"172","author":"Montorsi","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib20","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1210\/en.2003-1699","article-title":"Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa","volume":"145","author":"Morelli","year":"2004","journal-title":"Endocrinol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib21","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1464-410X.2008.08267.x","article-title":"Tadalafil and vardenafil vs sildenafil: a review of patient-preference studies","volume":"103","author":"Mirone","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.clinthera.2011.09.029_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.urology.2006.05.009","article-title":"Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction","volume":"68","author":"Shabsigh","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2011.09.029_bib23","series-title":"Cialis [package insert]","year":"2011"},{"key":"10.1016\/j.clinthera.2011.09.029_bib24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.eururo.2008.04.048","article-title":"Effect of sildenafil on middle-aged sexually active males with no erectile complaints: a randomized placebo-controlled double-blind study","volume":"55","author":"Gruenwald","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amjcard.2005.03.065","article-title":"Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)","volume":"96","author":"Kostis","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib26","series-title":"Viagra [package insert]","year":"2011"},{"key":"10.1016\/j.clinthera.2011.09.029_bib27","series-title":"Levitra [package insert]","year":"2011"},{"key":"10.1016\/j.clinthera.2011.09.029_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/0091270002250604","article-title":"Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction","volume":"43","author":"Rajogopalan","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib29","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1742-1241.2007.01482.x","article-title":"Current safety and tolerability issues in men with erectile dysfunction receiving PDE5 inhibitors","volume":"61","author":"Helstrom","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clinthera.2011.09.029_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1517\/14656566.4.3.397","article-title":"Long-term use of sildenafil","volume":"4","author":"Carson","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clinthera.2011.09.029_bib31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.eururo.2004.04.025","article-title":"Efficacy of sildenafil citrate at 12 hours after dosing: re-exploring the therapeutic window","volume":"46","author":"Moncada","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib32","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.urology.2007.12.025","article-title":"Randomized, double-blind, crossover trial of sildenafil in men with mild to moderate erectile dysfunction: efficacy at 8 and 12 hours postdose","volume":"71","author":"McCullough","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2011.09.029_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0090-4295(03)00359-5","article-title":"Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial","volume":"62","author":"Porst","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2011.09.029_bib34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.ju.0000106970.97082.61","article-title":"Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy","volume":"171","author":"Schwartz","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eururo.2005.12.005","article-title":"Optimisation of PDE5 inhibitor therapy in men with erectile dysfunction: converting \u201cnon-responders\u201d into \u201cresponders.\u201d","volume":"50","author":"Eardley","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib36","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.juro.2009.08.025","article-title":"Effect of chronic sildenafil on penile endothelial function: a randomized, double-blind, placebo-controlled study","volume":"182","author":"Vardi","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00345-005-0021-7","article-title":"Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors","volume":"23","author":"Sommer","year":"2005","journal-title":"World J Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.ijir.3901573","article-title":"Early penile rehabilitation following radical prostatectomy: Cleveland Clinic experience","volume":"20","author":"Raina","year":"2008","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.clinthera.2011.09.029_bib39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/ijir.2008.33","article-title":"Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy","volume":"20","author":"Padma-Nathan","year":"2008","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.clinthera.2011.09.029_bib40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1743-6109.2007.00700.x","article-title":"Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled triad","volume":"5","author":"McCullough","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2011.09.029_bib41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.eururo.2008.10.028","article-title":"Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application","volume":"55","author":"Hatzimouratidis","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.eururo.2006.02.052","article-title":"Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"50","author":"Porst","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.ijir.3901496","article-title":"Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US","volume":"19","author":"Rajfer","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.clinthera.2011.09.029_bib44","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1464-5491.2007.02338.x","article-title":"Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction","volume":"25","author":"Hatzichristou","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2011.09.029_bib45","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1111\/j.1743-6109.2008.00935.x","article-title":"Long term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction","volume":"5","author":"Porst","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2011.09.029_bib46","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.eururo.2008.03.056","article-title":"Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE study","volume":"54","author":"Zumbe","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.juro.2010.09.035","article-title":"Onset of efficacy of tadalafil once daily in men with erectile dysfunction: a randomized, double-blind, placebo controlled trial","volume":"185","author":"Seftel","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib48","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1185\/03007990802498440","article-title":"Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option","volume":"24","author":"Donatucci","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"12B Suppl","key":"10.1016\/j.clinthera.2011.09.029_bib49","doi-asserted-by":"crossref","first-page":"42M","DOI":"10.1016\/j.amjcard.2005.07.011","article-title":"Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on \u03b1-blocker interactions","volume":"96","author":"Kloner","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1742-1241.2001.tb11009.x","article-title":"Efficacy and safety of sildenafil citrate for the treatment of erectile dysfunction in men with cardiovascular disease","volume":"55","author":"Olsson","year":"2001","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clinthera.2011.09.029_bib51","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11934-007-0053-1","article-title":"Phosphodiesterase type 5 inhibitors, visual changes, and nonarteritic anterior ischemic optic neuropathy: is there a link?","volume":"8","author":"Haztimouratidis","year":"2007","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.clinthera.2011.09.029_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1743-6109.2005.00194.x","article-title":"Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction","volume":"3","author":"Laties","year":"2006","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2011.09.029_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9394(14)70999-7","article-title":"Incidence of nonarteritic anterior ischemic optic neuropathy","volume":"123","author":"Hattenhauer","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib54","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1136\/bjo.2007.125880","article-title":"Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association","volume":"91","author":"Danesh-Meyer","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3129\/can j ophthalmol.06-122","article-title":"Visual loss associated with erectile dysfunction drugs","volume":"42","author":"Dundar","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib56","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1368-5031.2006.00904.x","article-title":"Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy","volume":"60","author":"Gorkin","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"Pt 3A","key":"10.1016\/j.clinthera.2011.09.029_bib57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/eye.1999.90","article-title":"Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy","volume":"13","author":"Salomon","year":"1999","journal-title":"Eye"},{"key":"10.1016\/j.clinthera.2011.09.029_bib58","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/lary.20511","article-title":"Sudden hearing loss from PDE-5 inhibitors: a possible cellular stress etiology","volume":"119","author":"Maddox","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.clinthera.2011.09.029_bib59","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1017\/S002221510900423X","article-title":"Effect of phosphodiesterase-5 inhibitor on hearing","volume":"123","author":"Okuyugu","year":"2009","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib60","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1592\/phco.30.1.112","article-title":"Sudden sensorineural hearing loss associated with vardenafil","volume":"30","author":"Snodgrass","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2011.09.029_bib61","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1097\/01.ju.0000096221.67967.ae","article-title":"Salvage of sildenafil failures referred from primary care physicians","volume":"170","author":"Atiemo","year":"2003","journal-title":"J Urol"},{"issue":"Suppl 2B","key":"10.1016\/j.clinthera.2011.09.029_bib62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0090-4295(02)01688-6","article-title":"Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction","volume":"60","author":"McCullough","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2011.09.029_bib63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1464-410x.2001.00998.x","article-title":"A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction","volume":"87","author":"Meuleman","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.clinthera.2011.09.029_bib64","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.ijir.3901498","article-title":"Early sildenafil optimization and personalized instruction improves the frequency, flexibility, and success of sexual intercourse in men with erectile dysfunction","volume":"19","author":"McCullough","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.clinthera.2011.09.029_bib65","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.urology.2004.09.013","article-title":"Sildenafil citrate and vacuum device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy","volume":"65","author":"Raina","year":"2005","journal-title":"Urology"},{"issue":"2 Pt 2","key":"10.1016\/j.clinthera.2011.09.029_bib66","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/01.ju.0000075120.89700.9b","article-title":"Viability and safety of combination drug therapies for erectile dysfunction","volume":"170","author":"Steers","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib67","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/BF03349232","article-title":"Which patients with sexual dysfunction are suitable for testosterone replacement therapy?","volume":"30","author":"Morelli","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.clinthera.2011.09.029_bib68","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ageing\/afi003","article-title":"Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status","volume":"34","author":"Haren","year":"2005","journal-title":"Age Aging"},{"key":"10.1016\/j.clinthera.2011.09.029_bib69","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.urology.2003.11.009","article-title":"Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging","volume":"63","author":"Cavallini","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2011.09.029_bib70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archpsyc.57.2.141","article-title":"A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms","volume":"57","author":"Rabkin","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2011.09.029_bib71","first-page":"440","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients\u20142002 update","volume":"8","year":"2002","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clinthera.2011.09.029_bib72","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.ijir.3900936","article-title":"High dose sildenafil citrate as a salvage therapy for severe erectile dysfunction","volume":"14","author":"McMahon","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.clinthera.2011.09.029_bib73","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.urology.2006.03.005","article-title":"Vardenafil rescue rates of sildenafil nonresponders: objective assessment of 327 patients with erectile dysfunction","volume":"68","author":"Brisson","year":"2006","journal-title":"Urology"},{"issue":"Suppl 3A","key":"10.1016\/j.clinthera.2011.09.029_bib74","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.urology.2006.05.047","article-title":"Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective","volume":"68","author":"Jackson","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2011.09.029_bib75","doi-asserted-by":"crossref","first-page":"13C","DOI":"10.1016\/S0002-9149(99)00043-0","article-title":"Effects of sildenafil citrate on human hemodynamics","volume":"83","author":"Jackson","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib76","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/BF03349261","article-title":"The use of phosphodiesterase 5 inhibitors with concomitant medications","volume":"31","author":"Corona","year":"2008","journal-title":"J Endocrinol Invest"},{"issue":"9A","key":"10.1016\/j.clinthera.2011.09.029_bib77","doi-asserted-by":"crossref","first-page":"47M","DOI":"10.1016\/S0002-9149(03)00075-4","article-title":"Cardiovascular effects of tadalafil in patients on common antihypertensive therapies","volume":"92","author":"Kloner","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib78","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.ijir.3901360","article-title":"Efficacy of tadalafil in the treatment of erectile dysfunction in hypertensive men on concomitant thiazide diuretic therapy","volume":"17","author":"Kloner","year":"2005","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.clinthera.2011.09.029_bib79","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/157488607779315462","article-title":"Sildenafil is well tolerated by erectile dysfunction patients taking antihypertensive medications, including those on multidrug regimens","volume":"2","author":"Bohm","year":"2007","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.clinthera.2011.09.029_bib80","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1743-6109.2005.00150.x","article-title":"Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives","volume":"2","author":"van Ahlen","year":"2005","journal-title":"J Sex Med"},{"key":"10.1016\/j.clinthera.2011.09.029_bib81","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1001\/jama.294.23.2996","article-title":"Erectile dysfunction and subsequent cardiovascular disease","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2011.09.029_bib82","first-page":"187","article-title":"The relationship between erectile dysfunction and cardiovascular disease","volume":"9","author":"Kapur","year":"2008","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.clinthera.2011.09.029_bib83","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4065\/84.2.108","article-title":"A population-based longitudinal study of erectile dysfunction and future coronary artery disease","volume":"84","author":"Inman","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2011.09.029_bib84","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/sj.ijir.3901604","article-title":"Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen Study","volume":"20","author":"Schouten","year":"2008","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.clinthera.2011.09.029_bib85","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jacc.2003.09.023","article-title":"Time course of the interaction between tadalafil and nitrates","volume":"42","author":"Kloner","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib86","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.juro.2009.11.014","article-title":"Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12 week clinical trial","volume":"183","author":"Dmochowski","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib87","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.eururo.2009.04.039","article-title":"Combination of alfuzosin and tadalafil exerts an additive relaxant effect on human detrusor and prostatic tissues in vitro","volume":"57","author":"Oger","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib88","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.juro.2006.10.055","article-title":"Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial","volume":"177","author":"McVary","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib89","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.juro.2008.06.079","article-title":"Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study","volume":"180","author":"Roehrborn","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2011.09.029_bib90","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/j.1743-6109.2008.00940.x","article-title":"Comparative efficacy assessment of tamsulosin vs tamsulosin plus tadalafil in the treatment of LUTS\/BPH","volume":"5","author":"Bechara","year":"2008","journal-title":"J Sex Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811006709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811006709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T20:44:39Z","timestamp":1686429879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811006709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":90,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0149291811006709"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.09.029","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}